Genmab — April 2017

[JKY_VH]

Thank you GM. I am assuming that you are not employed by HSBC:-)

[bibob]

He suddently is not

[GlobalMacro 0]

haha!

[Budweis]

http://www.journalofclinicalpathways.com/article/daratumumab-cost-effective-refractory-multiple-myeloma

[Budweis]

Daratumumab Cost-Effective for Refractory Multiple Myeloma

[Helge_LarsenPI-redaktør]

God morgen.

[Helge_LarsenPI-redaktør]

Tak for link Bud.

[bibob]

God morgen.

[bibob]

Tak for link Budweis. Ser ud til at FDA er blevet mere prisbevidste. Godt for DARA.

[JKY_VH]

Tak Budweis og god morgen

[bibob]

http://www.journalofclinicalpathways.com/basic-page/best-therapy-combination-multiple-myeloma

[bibob]

http://www.journalofclinicalpathways.com/article/meta-analysis-reveals-optimal-combination-therapy-multiple-myeloma

[transalp]

Tak for dagens link.. Godt at se dara er fornuftigt prissat..

[gentogen]

Tak for super links og den fine søndagschat. Jeg tør næsten ikke dele Global Macros optimisme, men er nu sådan set meget enig i de grundlæggende tanker

[E_L]

http://www.newswire.ca/news-releases/janssen-inc-receives-health-canada-approval-of-darzalex-daratumumab-by-priority-review-for-patients-with-multiple-myeloma-who-have-had-at-least-one-prior-therapy-619600403.html Janssen Inc. Receives Health Canada Approval of DARZALEX (daratumumab) by Priority Review for Patients with Multiple Myeloma Who Have Had At Lea
st One Prior Therapy

[JKY_VH]

Thank you E L:-)

[JKY_VH]

Canada er ca 10% af US

[bibob]

Thank`s E L . That means Dara could be a potientiel Blockbuster in Canada over time. Or almost. Sounds good to me.

[Bulder]

Kommer jo an på om staten vil støtte Darzalex i kombinationerne. Det ville de jo ikke med monoterapi. Spørgsmålet om funding står endnu tilbage, står der i pressemeddelelsen.

[bibob]

Ja det er korrekt Bulder. Derfor skrev jeg også ( potientiel Blockbuster )